JPH11222405A - Antimicrobial composition for industrial use and antimicrobial treatment - Google Patents

Antimicrobial composition for industrial use and antimicrobial treatment

Info

Publication number
JPH11222405A
JPH11222405A JP3800498A JP3800498A JPH11222405A JP H11222405 A JPH11222405 A JP H11222405A JP 3800498 A JP3800498 A JP 3800498A JP 3800498 A JP3800498 A JP 3800498A JP H11222405 A JPH11222405 A JP H11222405A
Authority
JP
Japan
Prior art keywords
component
weight
halogen atom
dibromo
antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3800498A
Other languages
Japanese (ja)
Inventor
Hitoshi Egawa
均 江川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHINTO FINE KK
Original Assignee
SHINTO FINE KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHINTO FINE KK filed Critical SHINTO FINE KK
Priority to JP3800498A priority Critical patent/JPH11222405A/en
Publication of JPH11222405A publication Critical patent/JPH11222405A/en
Pending legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain the subject composition having powerful antimicrobial and bacteriostatic activities and effective for a wide range of microorganisms by including three specified compounds. SOLUTION: This composition is obtained by including (A) a halocyanoacetamide compound of formula I (X is a halogen; Y is H or a halogen; R1 is H or a lower alkyl) (e.g. 2,2-dibromo-3-nitrilopropionamide), (B) 0.01-10 pts.wt. preferably 0.5-5 pts.wt. halogenated aliphatic nitroalcohol derivative of formula II [R2 is a halogen or a (hydroxy)alkyl] (e.g. 2-bromo-2- nitropropane-1,3-diol) per pt.wt. of the component A and (C) 0.01-10 pts.wt. preferably 0.5-1 pt.wt. halogenated acetic acid ester derivative of formula III (R3 is an alkylene or an alkenylene) [e.g. 1,4-bis(bromoacetoxy)-2-butene] per pt.wt. the sum of the components A and B.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、紙パルプ工業用分
野における抄紙工程中の細菌・真菌をはじめとする微生
物に由来するスライムの付着を防止するため、また塗
料、ラテックス、デンプンスラリー液紙用コーティング
カラー、洗浄水、冷却水、接着剤、金属加工油等の水を
ベースに作成されている工業用水系組成物が微生物汚染
による腐敗、変色、物性劣化を受けることを防止するた
めの抗菌組成物及び抗菌方法に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a pulp and paper industry for preventing the adhesion of slime derived from microorganisms such as bacteria and fungi in the papermaking process, and for coating paper, latex and starch slurry. An antibacterial composition for preventing industrial water-based compositions made based on water such as coating colors, washing water, cooling water, adhesives, metalworking oils, etc. from undergoing spoilage, discoloration, and deterioration in physical properties due to microbial contamination. And antimicrobial methods.

【0002】[0002]

【従来の技術】紙パルプ工業分野における抄紙工程で
は、紙を生産するために大量の水を使用しており、その
水には紙を生産するために必要な各種有機物が分散・溶
解しているため、細菌、真菌等の微生物の栄養源となり
やすい。製紙工程中で細菌・真菌等の微生物がそれら栄
養源を元にして繁殖し、粘液状の代謝産物を産出し、パ
ルプ、填料など製紙工程中に分散している製紙原料を取
り込んで、水流の淀んだチェスト内の壁面やフローボッ
クス等にスライムを形成する。形成されたスライムは、
徐々に増大しやがて離脱しパルプ等の製紙原料と共に紙
に抄き込まれ紙上の異物となってあらわれ、品質の低下
をまねく。また最近では、紙をかなり高速で抄くため、
最悪の場合断紙となり、生産性の低下を引き起こす。
2. Description of the Related Art In the papermaking process in the pulp and paper industry, a large amount of water is used to produce paper, and various organic substances necessary for producing paper are dispersed and dissolved in the water. Therefore, it is likely to be a nutrient source for microorganisms such as bacteria and fungi. During the papermaking process, microorganisms such as bacteria and fungi proliferate based on these nutrient sources, produce slimey metabolites, take in papermaking materials such as pulp and filler that are dispersed in the papermaking process, Slime is formed on the wall or flow box inside the stagnant chest. The formed slime is
It gradually increases and eventually comes off, is made into paper together with papermaking raw materials such as pulp, and appears as foreign matter on the paper, resulting in quality deterioration. Recently, to make paper at a very high speed,
In the worst case, the paper will be cut off, causing a drop in productivity.

【0003】また、塗料、ラテックス、デンプンスラリ
ー液等水をベースに作成されている工業用水系組成物に
ついても、細菌に汚染されることによって腐敗が生じ、
臭気の発生や粘度低下、pH変動等の物性劣化を引き起
こしたり、真菌(糸状菌)が繁殖することによってスト
レーナーの目詰まり、着色、異物混入等を引き起こす。
[0003] In addition, industrial water-based compositions prepared based on water, such as paints, latex, and starch slurries, also become spoiled by being contaminated by bacteria,
Occurrence of odor, deterioration of physical properties such as decrease in viscosity, fluctuation of pH, and the like are caused, and fungus (filamentous fungi) propagates, thereby causing clogging, coloring, and foreign matter mixing of the strainer.

【0004】抄紙工程における微生物要因によるスライ
ムの発生防止するために抗菌剤として各種の薬剤が使用
されてきた。またそれは各種水系組成物の腐敗防止を目
的とした抗菌剤においても同様である。たとえば抄紙工
程においては、殺菌力の非常に強い2,2−ジブロモ−
3−ニトリロプロピオンアミドをはじめ4,5−ジクロ
ロ−1,2−ジチオール−3−オンや静菌力にすぐれた
メチレンビスチオシアネート、1,4−ビス(ブロモア
セトキシ)−2−ブテン又は1,2−ビス(ブロモアセ
トキシ)エタンなどがよく使用されている。水系組成物
の腐敗防止には防腐という性格上、静菌力のすぐれ、水
系組成物中での安定性にすぐれた5−クロロ−2−メチ
ル−4−イソチアゾリン−3−オン、1,2−ベンズイ
ソチアゾリン−3−オン、2,2−ジブロモ−2−ニト
ロエタノール、2−ブロモ−2−ニトロプロパン−1,
3−ジオールなどがよく使用されている。
[0004] Various agents have been used as antibacterial agents to prevent the generation of slime due to microbial factors in the papermaking process. The same applies to antibacterial agents for the purpose of preventing spoilage of various aqueous compositions. For example, in the papermaking process, 2,2-dibromo-
In addition to 3-nitrilopropionamide, 4,5-dichloro-1,2-dithiol-3-one, methylenebisthiocyanate having excellent bacteriostatic power, 1,4-bis (bromoacetoxy) -2-butene or 1,2 -Bis (bromoacetoxy) ethane and the like are often used. To prevent spoilage of the aqueous composition, 5-chloro-2-methyl-4-isothiazolin-3-one, 1,2-, which has excellent bacteriostatic activity and excellent stability in the aqueous composition due to its preservative property. Benzisothiazolin-3-one, 2,2-dibromo-2-nitroethanol, 2-bromo-2-nitropropane-1,
3-diol and the like are often used.

【0005】しかし単一薬剤の長期に渡る連続使用は、
耐性菌の出現を招きやすいため、過去に種々の2成分又
は3成分の組み合わせによる抗菌剤が使用されてきた。
たとえば、2成分の組み合わせには、特公平7−453
66における4,5−ジクロロ−1,2−ジチオール−
3−オンと5−クロロ−2−メチル−4−イソチアゾリ
ン−3−オンの組み合わせ、特公平1−20121にお
ける2,2−ジブロモ−3−ニトリロプロピオンアミド
と4,5−ジクロロ−1,2−ジチオール−3−オンの
組み合わせなど多数開示されている。3成分の組み合わ
せには、特開平7−187920における2,2−ジブ
ロモ−3−ニトリロプロピオンアミドと4,5−ジクロ
ロ−1,2−ジチオール−3−オンと5−クロロ−2−
メチル−4−イソチアゾリン−3−オンの組み合わせ、
特開平7−25708における2,2−ジブロモ−3−
ニトリロプロピオンアミドとメチレンビスチオシアネー
トと2,2−ジブロモ−2−ニトロエタノールの組み合
わせなどが開示されている。これらの組み合わせは単一
薬剤が長期にわたって使用されていた製紙工程及び水系
組成物に対して良好な効力をもっているが、2成分、3
成分の組み合わせの薬剤が微生物を制御する手段として
一般的になり、組み合わせ配合でも長期使用による耐性
菌が出現し始めてきたため、さらなる殺菌、静菌効力を
もった低濃度で有効な薬剤が望まれている。
However, the long-term continuous use of a single drug is
Antibacterial agents using various combinations of two or three components have been used in the past because they are likely to cause the emergence of resistant bacteria.
For example, in the combination of two components,
4,5-Dichloro-1,2-dithiol- at 66
Combination of 3-one and 5-chloro-2-methyl-4-isothiazolin-3-one, 2,2-dibromo-3-nitrilopropionamide and 4,5-dichloro-1,2- A large number of combinations of dithiol-3-one are disclosed. Combinations of the three components include 2,2-dibromo-3-nitrilopropionamide, 4,5-dichloro-1,2-dithiole-3-one and 5-chloro-2-one described in JP-A-7-187920.
A combination of methyl-4-isothiazolin-3-one,
2,2-dibromo-3- as described in JP-A-7-25708
A combination of nitrilopropionamide, methylenebisthiocyanate, and 2,2-dibromo-2-nitroethanol is disclosed. These combinations have good potency in papermaking processes and aqueous compositions where a single agent has been used for a long time, but with two components,
Drugs in combination of components have become common as a means of controlling microorganisms, and even in combination formulations, resistant bacteria due to long-term use have begun to appear, so a drug effective at a low concentration with further sterilization and bacteriostatic efficacy is desired. ing.

【0006】[0006]

【発明が解決しようとする課題】本発明は、前記のよう
な要望に応えるため、従来の組み合わせでは不充分であ
った強力な殺菌力又は静菌力をもった、広範囲の微生物
に対して有効な薬剤を提供することにある。
SUMMARY OF THE INVENTION In order to meet the above demands, the present invention is effective against a wide range of microorganisms having a strong bactericidal or bacteriostatic power, which was insufficient with conventional combinations. In providing various drugs.

【0007】[0007]

【課題を解決するための手段】本発明者は、課題を解決
するために各種成分の組み合わせにおける効力の確認を
行い、鋭意研究を重ねた結果、(A)ハロシアノアセト
アミド化合物と(B)ハロゲン化脂肪族ニトロアルコー
ル誘導体及び(C)ハロゲン化酢酸エステル誘導体の3
種の有効成分を含有する工業用抗菌組成物が低濃度でも
良好な殺菌力、静菌力を併せ持つ非常に優れた抗菌組成
物であることを見いだした。すなわち本発明は(A)下
記一般式 (式中のXはハロゲン原子、Yは水素原子又はハロゲン
原子、R1 は水素原子又は低級アルキル基を示す)で表
されるハロシアノアセトアミド化合物、(B)下記一般
(式中のXはハロゲン原子、R2 はハロゲン原子又はア
ルキル基又はヒドロキシアルキル基を示す)で表される
ハロゲン化脂肪族ニトロアルコール誘導体及び(C)下
記一般式 (式中のXはハロゲン原子、R3 はアルキレン基又はア
ルケニレン基を示す)で表されるハロゲン化酢酸エステ
ル誘導体を含有することを特徴とする工業用抗菌組成物
であり、またこれらの有効成分を製紙工程白水又は工業
用水系組成物に1〜20000ppm添加する抗菌方法
である。
Means for Solving the Problems The present inventor has confirmed the efficacy of combinations of various components in order to solve the problems, and as a result of intensive studies, it has been found that (A) a halocyanoacetamide compound and (B) a halogen Aliphatic nitro alcohol derivatives and (C) halogenated acetate derivatives 3
It has been found that an industrial antibacterial composition containing various kinds of active ingredients is a very excellent antibacterial composition having good bactericidal and bacteriostatic properties even at a low concentration. That is, the present invention provides (A) the following general formula: (Wherein X represents a halogen atom, Y represents a hydrogen atom or a halogen atom, and R 1 represents a hydrogen atom or a lower alkyl group), (B) a general formula shown below. (Wherein X represents a halogen atom and R 2 represents a halogen atom or an alkyl group or a hydroxyalkyl group), and a halogenated aliphatic nitro alcohol derivative represented by the following formula: (Wherein X represents a halogen atom and R 3 represents an alkylene group or an alkenylene group). An industrial antibacterial composition comprising a halogenated acetate derivative represented by the following formula: Is an antibacterial method in which 1 to 20,000 ppm is added to papermaking process white water or an industrial water-based composition.

【0008】[0008]

【発明の実施の形態】本発明の(A)成分としては、一
般式 (式中のXはハロゲン原子、Yは水素原子又はハロゲン
原子、R1 は水素原子又は低級アルキル基を示す)で表
されるハロシアノアセトアミド化合物が用いられ、たと
えば2−クロロ−3−ニトリロプロピオンアミド、2−
ブロモ−3−ニトリロプロピオンアミド、2,2−ジク
ロロ−3−ニトリロプロピオンアミド、2,2−ジブロ
モ−3−ニトリロプロピオンアミドなどが含まれる。こ
れらは単独で用いても良いし、2種以上を組み合わせて
も良い。
BEST MODE FOR CARRYING OUT THE INVENTION The component (A) of the present invention has a general formula (Wherein X represents a halogen atom, Y represents a hydrogen atom or a halogen atom, and R 1 represents a hydrogen atom or a lower alkyl group), for example, 2-chloro-3-nitrilopropion Amide, 2-
Bromo-3-nitrilopropionamide, 2,2-dichloro-3-nitrilopropionamide, 2,2-dibromo-3-nitrilopropionamide and the like are included. These may be used alone or in combination of two or more.

【0009】本発明の(B)成分であるハロゲン化脂肪
族ニトロアルコール誘導体としては、一般式 (式中のXはハロゲン原子、R2 はハロゲン原子又はア
ルキル基又はヒドロキシアルキル基を示す)で表される
ハロゲン化脂肪族ニトロアルコール誘導体が用いられ、
たとえば2−ブロモ−2−ニトロプロパン−1,3−ジ
オール又は2,2−ジブロモ−2−ニトロ−1−エタノ
ールなどが含まれる。これらは単独で用いても良いし、
2種以上を組み合わせても良い。
The halogenated aliphatic nitro alcohol derivative which is the component (B) of the present invention has a general formula Wherein X represents a halogen atom, R 2 represents a halogen atom or an alkyl group or a hydroxyalkyl group, and a halogenated aliphatic nitro alcohol derivative represented by the formula:
For example, 2-bromo-2-nitropropane-1,3-diol or 2,2-dibromo-2-nitro-1-ethanol is included. These may be used alone,
Two or more types may be combined.

【0010】本発明の(C)成分としては、(C)一般
(式中のXはハロゲン原子、R3 はアルキレン基又はア
ルケニレン基を示す)で表されるハロゲン化酢酸エステ
ル誘導体が用いられ、たとえば1,4−ビス(ブロモア
セトキシ)−2−ブテン、1,2−ビス(ブロモアセト
キシ)エタン、1,4−ビス(クロロアセトキシ)−2
−ブテンなどが含まれる。
The component (C) of the present invention includes (C) a general formula (Wherein X represents a halogen atom and R 3 represents an alkylene group or an alkenylene group), and a halogenated acetate derivative represented by, for example, 1,4-bis (bromoacetoxy) -2-butene, 2-bis (bromoacetoxy) ethane, 1,4-bis (chloroacetoxy) -2
-Butene and the like.

【0011】(A)ハロシアノアセトアミド化合物は比
較的殺菌効力に優れ、(B)ハロゲン化脂肪族ニトロア
ルコール誘導体は比較的静菌効力に優れ、(C)ハロゲ
ン化酢酸エステル誘導体は比較的静菌効力に優れてお
り、それぞれの有効成分の効果が異なるので、本発明の
3種成分の内1種又は2種の配合量が極端に低いとその
効果が期待できないため成分(A)を1重量部に対し
て、成分(B)が0.1〜10重量部好ましくは0.5
〜5重量部で、成分(A)と成分(B)の合計量を1重
量部とした時、成分(C)0.01〜10重量部好まし
くは0.5〜1重量部を含む含有割合が望ましい。また
各々の有効成分を混ぜることによる効力の相乗作用の点
からもこの含有割合が望ましい。
(A) The halocyanoacetamide compound is relatively excellent in bactericidal activity, (B) the halogenated aliphatic nitro alcohol derivative is relatively excellent in bacteriostatic effect, and (C) the halogenated acetate derivative is relatively bacteriostatic. Since the effects are excellent and the effects of the respective active ingredients are different, the effect cannot be expected if one or two of the three components of the present invention are extremely low in compounding amount. Parts by weight of component (B) is 0.1 to 10 parts by weight, preferably 0.5 to 10 parts by weight.
When the total amount of the component (A) and the component (B) is 1 part by weight, the content of the component (C) is 0.01 to 10 parts by weight, preferably 0.5 to 1 part by weight. Is desirable. This content ratio is also desirable from the viewpoint of the synergistic effect of the effects obtained by mixing the respective active ingredients.

【0012】抗菌方法としては、上記3種の有効成分を
含有した抗菌組成物を添加してもよいし、上記3種の有
効成分をそれぞれ別々に添加しても良い。添加量は製紙
工程白水又は工業用水系組成物に1〜20000ppm
添加するのが好ましい。
As an antibacterial method, an antibacterial composition containing the above three kinds of active ingredients may be added, or the above three kinds of active ingredients may be separately added. The amount added is 1 to 20000 ppm in the papermaking process white water or industrial water-based composition.
It is preferred to add.

【0013】本発明の有効成分の抄紙工程中又は水系組
成物への添加方法は、各々別々でも、製剤化した混合物
でもよい。製剤化に際して用いられる溶媒、界面活性剤
などは特に限定しない。しかし、微生物の増殖を引き起
こす抄紙工程水や水系組成物などの薬剤添加対象物が水
を主とした組成であるため、溶媒は比較的親水性のもの
が望ましい。
The method of adding the active ingredient of the present invention to the aqueous composition during the papermaking process or to the aqueous composition may be either separately or in the form of a formulated mixture. The solvent, surfactant and the like used in the formulation are not particularly limited. However, since the chemicals to be added such as water in the papermaking process and aqueous compositions that cause the growth of microorganisms are mainly composed of water, the solvent is preferably relatively hydrophilic.

【0014】溶媒としては、エチレングリコール、プロ
ピレングリコール、ジエチレングリコール、トリエチレ
ングリコール、ジプロピレングリコール、ヘキシレング
リコールなどのグリコール系溶剤、ジエチレングリコー
ルモノメチルエーテル、ジエチレングリコールモノエチ
ルエーテル、ジエチレングリコールモノブチルエーテル
などのグリコールエーテル系溶剤やプロピレンカーボネ
ートなどが使用できる。これらはこれらは単独で用いて
も良いし、2種以上を組み合わせも良く、有効成分の3
種を溶解できる添加量があれば良い。
Examples of the solvent include glycol solvents such as ethylene glycol, propylene glycol, diethylene glycol, triethylene glycol, dipropylene glycol, and hexylene glycol, and glycol ether solvents such as diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, and diethylene glycol monobutyl ether. And propylene carbonate. These may be used alone or in combination of two or more.
It is sufficient if there is an added amount capable of dissolving the seed.

【0015】界面活性剤としては非イオン系界面活性
剤、陰イオン系界面活性剤、陽イオン系界面活性剤、両
イオン系界面活性剤などが使用できる。
As the surfactant, a nonionic surfactant, an anionic surfactant, a cationic surfactant, a zwitterionic surfactant and the like can be used.

【0016】[0016]

【実施例】次に本発明の実施例および比較例をあげて説
明するが、本発明はこれらに限定されるものではない。
下表に示した配合比率はすべて重量%である。また、各
実施例の抗菌組成物は各実施例に示す各成分をそれぞれ
示す割合で常温において通常の撹拌によって調製した。
EXAMPLES Next, the present invention will be described with reference to examples and comparative examples, but the present invention is not limited to these examples.
All the compounding ratios shown in the following table are% by weight. Further, the antimicrobial compositions of the respective examples were prepared by ordinary stirring at room temperature at the indicated ratios of the respective components shown in the respective examples.

【0017】実施例1〜6 表1に示す抗菌剤組成物を調製し、試験例1、試験例
2、試験例3、試験例4により、その性能を調べた。な
お表中の有効成分の表示は以下の略語にて表す。
Examples 1 to 6 The antibacterial agent compositions shown in Table 1 were prepared, and their performance was examined in Test Example 1, Test Example 2, Test Example 3, and Test Example 4. The indication of the active ingredient in the table is represented by the following abbreviations.

【0018】2,2−ジブロモ−3−ニトリロプロピオ
ンアミド :DBNPA(A成分) 2,2−ジブロモ−2−ニトロ−1−エタノール :
DBNE(B成分) 1,4−ビス(ブロモアセトキシ)−2−ブテン :
BBAB(C成分)
2,2-dibromo-3-nitrilopropionamide: DBNPA (component A) 2,2-dibromo-2-nitro-1-ethanol:
DBNE (component B) 1,4-bis (bromoacetoxy) -2-butene:
BBAB (C component)

【0019】[0019]

【表1】 [Table 1]

【0020】比較例1〜4 表2に示す抗菌剤組成物を調製し、試験例1、試験例
2、試験例3により、その性能を調べた。
Comparative Examples 1 to 4 The antibacterial agent compositions shown in Table 2 were prepared, and their performances were examined in Test Examples 1, 2, and 3.

【0021】[0021]

【表2】 [Table 2]

【0022】試験例1.製紙工程白水に対する殺菌力評
価 「試験方法」実施例及び比較例の製剤品を所定濃度添加
した下記対象試料を培養し、菌数の経時変化を変性ワッ
クスマン寒天平板混釈法(試料を滅菌水で希釈し、この
一定量を滅菌シャーレにとり、溶解した変性ワックスマ
ン寒天培地を注入し、混釈した後固化させる。30℃の
恒温室内で2日間培養後形成されたコロニー数をカウン
トする。)にて測定した。 対象試料:製紙工程白水、上質紙抄造、pH6.9、生
菌数2.0×107 CFU/ml 「試験結果」各製剤品を添加後30分、60分後の菌数
値を測定し、薬剤無添加試料の菌数値と製剤品添加試料
の菌数値の増減値差を表3に示した。 増減値差:所定時間後の薬剤無添加試料の菌数の対数値製剤品添
加試料の菌数の対数値 値が大きい方が殺菌効力が大きい。「考察」表3に示し
たように比較例1〜3の単独の有効成分の製剤品、比較
例4〜6の2種の有効成分の製剤品の増減値差に比べ
て、実施例1〜3の3種の有効成分の製剤品の増減値差
は明らかに大きい値を示し、有効成分各々単独又は2種
混合の製剤品に比べて3種混合の製剤品は製紙工程白水
に対して顕著な殺菌力を示すことが確認された。
Test Example 1 Evaluation of bactericidal activity against white water in the papermaking process “Test method” The following target samples to which the preparations of Examples and Comparative Examples were added at a predetermined concentration were cultured, and the time-dependent change in the number of bacteria was measured using a modified Waxman agar plate pour method (sterile water , And a fixed amount thereof is taken in a sterile petri dish, and a dissolved denatured Waxman agar medium is injected, and the mixture is solidified after being pulverized. The number of colonies formed after culturing in a thermostat chamber at 30 ° C for 2 days is counted. Was measured. Target sample: papermaking process white water, fine papermaking, pH 6.9, viable cell count 2.0 × 10 7 CFU / ml “Test result” 30 minutes and 60 minutes after adding each preparation, Table 3 shows the difference between the bacterial value of the sample without the drug and the bacterial value of the sample with the preparation. Difference in increase / decrease value: Logarithmic value of bacterial count of drug-free sample after predetermined time-Addition to drug product
The larger the logarithmic value of the number of bacteria in the added sample, the greater the bactericidal effect. [Consideration] As shown in Table 3, the difference between the increase / decrease value of the preparations of the single active ingredients in Comparative Examples 1 to 3 and the increase / decrease value of the preparations of the two active ingredients in Comparative Examples 4 to 6 was observed. The difference between the increase and decrease of the preparations of the three active ingredients is significantly large, and the preparation of the three kinds of the active ingredients is more remarkable for the white water in the paper making process than the preparation of the single or two kinds of the active ingredients. It was confirmed that the bactericidal bactericide exhibited a high sterilizing power.

【0023】[0023]

【表3】 [Table 3]

【0024】試験例2.製紙工程白水に対する静菌力評
価 「試験方法」実施例及び比較例の製剤品を下記対象試料
を無菌濾過したものに所定濃度添加後、10倍濃度変性
ワックスマン液体培地を1%添加、対象試料を接種用と
してそのまま1%添加した。比濁法による濁度の変化を
経時的に記録した微生物増殖曲線によって、静菌力を測
定した。 対象試料:製紙工程白水、上質紙抄造、pH6.9、生
菌数2.0×107 CFU/ml 「試験結果」薬剤無添加試料の微生物増殖曲線の立ち上
がり時間と各製剤品添加試料の微生物増殖曲線の立ち上
がり時間との差を表4に示した。 差:各製剤品添加試料の立ち上がり時間薬剤無添加試
料の立ち上がり時間 差の値が大きい程、静菌効力が大きい。「考察」表4に
示したように比較例1〜3の単独の有効成分の製剤品、
比較例4〜6の2種の有効成分の製剤品の薬剤無添加試
料との立ち上がり時間の差に比べて、実施例1〜3の3
種の有効成分の製剤品の立ち上がり時間の差は明らかに
大きい値を示し、有効成分各々単独又は2種混合の製剤
品に比べて3種混合の製剤品は製紙工程白水に対して顕
著な静菌力を示すことが確認された。
Test Example 2. Evaluation of bacteriostatic activity against white water in the papermaking process "Test method" After adding the specified concentrations of the preparations of Examples and Comparative Examples to the following target samples aseptically filtered, adding 1% of a 10-fold concentration of modified Waxman liquid medium, Was directly added for inoculation at 1%. The bacteriostatic power was measured by a microbial growth curve in which the change in turbidity by the turbidimetry was recorded with time. Target samples: papermaking process white water, fine papermaking, pH 6.9, viable cell count 2.0 × 10 7 CFU / ml “Test result” Rise time of microbial growth curve of drug-free sample and microorganism of sample with each drug product Table 4 shows the difference from the rise time of the growth curve. Difference: rise time of each drug product-added sample- drug-free test
The greater the value of the difference between the rise times of the ingredients, the greater the bacteriostatic efficacy. [Discussion] As shown in Table 4, a preparation of a single active ingredient of Comparative Examples 1 to 3,
In comparison with the difference in the rise time between the preparations of the two active ingredients of Comparative Examples 4 to 6 and the drug-free sample, 3 to 3 of Examples 1 to 3
The difference between the rise times of the preparations of the various active ingredients shows a clearly large value, and the preparation of the three kinds of the active ingredients has a remarkable static resistance to white water in the papermaking process as compared with the preparation of the single kind or the mixture of the two kinds. It was confirmed that it exhibited bacterial activity.

【0025】[0025]

【表4】 [Table 4]

【0026】試験例3.SBRラテックスの防腐評価 「試験方法」SBRラテックス(pH7.9)を滅菌ポ
リプロピレン瓶に30g分注し薬剤を所定量添加した
後、あらかじめ腐敗させたSBRラテックス(菌数:
3.0×107 )を1%接種した。これを密閉静置条件
で30℃で培養し、TGC寒天平板混釈法によって経時
的な生菌数を測定し、防腐効果を判定した。また、生菌
数測定後、腐敗品を1週間毎に、1%接種した。「試験
結果」下記の判定基準をもって判定し、試験結果を表5
に示した。 「考察」表5に示したように比較例1〜3の単独の有効
成分の製剤品、比較例4〜6の2種の有効成分の製剤品
の28日目の評価結果は+++〜+++であるのに対し
て、実施例1〜3の3種の有効成分の評価結果は−〜+
で、有効成分各々単独又は2種混合の製剤品に比べて3
種混合の製剤品はSBRラテックスに対して顕著な防腐
効力を示すことが確認された。
Test Example 3 Preservative evaluation of SBR latex "Test method" 30 g of SBR latex (pH 7.9) was dispensed into a sterilized polypropylene bottle, a predetermined amount of a drug was added thereto, and the SBR latex (precipitated:
3.0 × 10 7 ) was inoculated at 1%. This was cultured at 30 ° C. in a closed and stationary condition, and the viable cell count over time was measured by TGC agar plate pour method to determine the preservative effect. After the viable cell count, 1% of the spoiled product was inoculated weekly. "Test results" Judgment was made according to the following criteria.
It was shown to. [Discussion] As shown in Table 5, the evaluation results on the 28th day of the preparations of the single active ingredients of Comparative Examples 1 to 3 and the preparations of the two active ingredients of Comparative Examples 4 to 6 were +++ to +++. On the other hand, the evaluation results of the three types of active ingredients in Examples 1 to 3 are-to +
In comparison with the preparation of the active ingredient alone or a mixture of two kinds,
It was confirmed that the seed mixture preparation exhibited a remarkable antiseptic effect on SBR latex.

【0027】[0027]

【表5】 [Table 5]

【0028】[0028]

【発明の効果】以上のように本発明を適用した場合、従
来の単独又は2種混合の組み合わせでは不充分であった
強力な殺菌力、長時間にわたる静菌力、長期間にわたる
防腐効力を合わせ持った抗菌組成物または抗菌方法の提
供が可能である。
As described above, when the present invention is applied, a strong bactericidal power, a long-lasting bacteriostatic power, and a long-term antiseptic effect, which were insufficient with the conventional single or combination of two kinds, are combined. It is possible to provide an antimicrobial composition or an antimicrobial method having the same.

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 (A)一般式 (式中のXはハロゲン原子、Yは水素原子又はハロゲン
原子、R1 は水素原子又は低級アルキル基を示す)で表
されるハロシアノアセトアミド化合物、 (B)一般式 (式中のXはハロゲン原子、R2 はハロゲン原子又はア
ルキル基又はヒドロキシアルキル基を示す)で表される
ハロゲン化脂肪族ニトロアルコール誘導体及び (C)一般式 (式中のXはハロゲン原子、R3 はアルキレン基又はア
ルケニレン基を示す)で表されるハロゲン化酢酸エステ
ル誘導体を含有することを特徴とする工業用抗菌組成
物。
(A) General formula (Wherein X is a halogen atom, Y is a hydrogen atom or a halogen atom, and R 1 is a hydrogen atom or a lower alkyl group), (B) a general formula (Wherein X represents a halogen atom, R 2 represents a halogen atom or an alkyl group or a hydroxyalkyl group) and a halogenated aliphatic nitro alcohol derivative represented by the following formula: (Wherein X represents a halogen atom and R 3 represents an alkylene group or an alkenylene group). An industrial antibacterial composition comprising a halogenated acetate derivative represented by the following formula:
【請求項2】成分(A)を1重量部に対して、成分
(B)が0.1〜10重量部好ましくは0.5〜5重量
部で、成分(A)と成分(B)の合計量を1重量部とし
た時、成分(C)0.01〜10重量部好ましくは0.
5〜1重量部を含む請求項1記載の工業用抗菌組成物。
2. Component (A) is used in an amount of 0.1 to 10 parts by weight, preferably 0.5 to 5 parts by weight, based on 1 part by weight of component (A). When the total amount is 1 part by weight, component (C) is 0.01 to 10 parts by weight, preferably 0.1 to 10 parts by weight.
The industrial antibacterial composition according to claim 1, comprising 5 to 1 part by weight.
【請求項3】成分(A)が2,2−ジブロモ−3−ニト
リロプロピオンアミド、成分(B)が2−ブロモ−2−
ニトロプロパン−1,3−ジオール又は2,2−ジブロ
モ−2−ニトロ−1−エタノール、成分(C)が1,4
−ビス(ブロモアセトキシ)−2−ブテン又は1,2−
ビス(ブロモアセトキシ)エタンである請求項1記載の
工業用抗菌組成物。
3. Component (A) is 2,2-dibromo-3-nitrilopropionamide and component (B) is 2-bromo-2-
Nitropropane-1,3-diol or 2,2-dibromo-2-nitro-1-ethanol, wherein component (C) is 1,4
-Bis (bromoacetoxy) -2-butene or 1,2-
The industrial antibacterial composition according to claim 1, which is bis (bromoacetoxy) ethane.
【請求項4】請求項1記載の工業用抗菌組成物を製紙工
程白水又は工業用水系組成物に1〜20000ppm添
加することを特徴とする抗菌方法。
4. An antibacterial method comprising adding the industrial antibacterial composition according to claim 1 to a papermaking process white water or an industrial aqueous composition in an amount of 1 to 20,000 ppm.
JP3800498A 1998-02-03 1998-02-03 Antimicrobial composition for industrial use and antimicrobial treatment Pending JPH11222405A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3800498A JPH11222405A (en) 1998-02-03 1998-02-03 Antimicrobial composition for industrial use and antimicrobial treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3800498A JPH11222405A (en) 1998-02-03 1998-02-03 Antimicrobial composition for industrial use and antimicrobial treatment

Publications (1)

Publication Number Publication Date
JPH11222405A true JPH11222405A (en) 1999-08-17

Family

ID=12513440

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3800498A Pending JPH11222405A (en) 1998-02-03 1998-02-03 Antimicrobial composition for industrial use and antimicrobial treatment

Country Status (1)

Country Link
JP (1) JPH11222405A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000067578A1 (en) * 1999-05-10 2000-11-16 Somar Corporation Composite bactericidal compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000067578A1 (en) * 1999-05-10 2000-11-16 Somar Corporation Composite bactericidal compositions

Similar Documents

Publication Publication Date Title
JPS5950642B2 (en) industrial disinfectant
JPS6360722B2 (en)
JPS61191601A (en) Control of microbes in water-containing composition
JP4141542B2 (en) Industrial disinfectant and disinfecting method using the same
JPH10287511A (en) Antimicrobial and algicidal agent for nonmedical use and prevention of microorganism and alga
JPH11222405A (en) Antimicrobial composition for industrial use and antimicrobial treatment
JP4136048B2 (en) Industrial antimicrobial composition and antimicrobial method
JP4726333B2 (en) Industrial antibacterial composition and antibacterial method
JPH10298006A (en) Sterilization composition for industry and sterilization
JP2000080002A (en) Antimicrobial composition for industrial purpose and antimicrobial method
JP2000063211A (en) Industrial antimicrobial agent composition and antimicrobial method
JPH02250805A (en) Industrial bactericide
JP4141018B2 (en) Industrial antibacterial agent composition and antibacterial method
JP3754987B2 (en) Industrial sterilization / bacteriostatic agent and industrial sterilization / bacteriostatic method
JP4149045B2 (en) Industrial antibacterial agent composition and antibacterial method
JP3848970B2 (en) Industrial disinfectant / bacteriostatic agent and industrial disinfectant / bacteriostatic method
JP2891635B2 (en) Industrial fungicides
JP2891629B2 (en) Industrial bactericidal and bacteriostatic agents
JP2001261509A (en) Industrial antimicrobial agent composition and industrial antimicrobial method
JPH1017413A (en) Exterminating agent for harmful microorganism and extermination of harmful microorganism in white water system using the same
KR100285282B1 (en) Disinfectant composition
JP2000063212A (en) Industrial antimicrobial agent composition and antimicrobial method
JPH11322510A (en) Industrial antimicrobial agent composition and antimicrobial method
JP4061442B2 (en) Industrial antibacterial agent composition and antibacterial method
JPS60231603A (en) Antimicrobial agent

Legal Events

Date Code Title Description
A621 Written request for application examination

Effective date: 20041109

Free format text: JAPANESE INTERMEDIATE CODE: A621

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20070611

A131 Notification of reasons for refusal

Effective date: 20080313

Free format text: JAPANESE INTERMEDIATE CODE: A131

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080502

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080527